Frazier Life Sciences Management L.P. cut its holdings in shares of Tyra Biosciences, Inc. (NASDAQ:TYRA – Free Report) by 0.2% during the fourth quarter, Holdings Channel reports. The fund owned 1,026,420 shares of the company’s stock after selling 1,593 shares during the period. Frazier Life Sciences Management L.P.’s holdings in Tyra Biosciences were worth $14,216,000 […]
Tyra Biosciences, Inc. (NASDAQ:TYRA – Get Free Report) shares dropped 3.3% during mid-day trading on Wednesday . The company traded as low as $19.42 and last traded at $19.55. Approximately 67,343 shares changed hands during trading, a decline of 49% from the average daily volume of 133,029 shares. The stock had previously closed at $20.22. […]
Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA – Get Free Report) dropped 3.3% during trading on Wednesday . The stock traded as low as $19.42 and last traded at $19.55. Approximately 67,343 shares traded hands during trading, a decline of 49% from the average daily volume of 133,029 shares. The stock had previously closed at $20.22. […]
Contineum Therapeutics, Inc. , a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies that target biological pathways associated with.